<Disease><Name>DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY</Name><Synonym>SEPIAPTERIN REDUCTASE DEFICIENCY</Synonym><OMIM><Number>612716</Number><URL>http://omim.org/entry/612716</URL></OMIM><Orphanet><Number>70594</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=70594</URL></Orphanet><Protein><Number>Sepiapterin reductase</Number><URL>http://www.uniprot.org/uniprot/P35270</URL></Protein><ExPASy><Number>1.1.1.153</Number><URL>http://enzyme.expasy.org/EC/1.1.1.153</URL></ExPASy><Gene>2p14-p12</Gene><ICD>G24.1</ICD><Summary>rare (&lt;1:1000000);autosomal recessive</Summary><Symptoms><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2323</id><symptom>behavior, abnormal or bizarre, confusion / behaviour, abnormal or bizarre</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3801</id><symptom>behavior, aggressive</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1955</id><symptom>behavior, hyperactive, restless / behaviour, hyperactive, restless</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1945</id><symptom>chorea or athetosis</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3460</id><symptom>cognitive impairment / cognitive dysfunction</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1961</id><symptom>cortical or cerebral atrophy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3624</id><symptom>diurnal fluctuation of symptom</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2164</id><symptom>dysarthria</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1946</id><symptom>dystonia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1969</id><symptom>extrapyramidal signs</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3628</id><symptom>gastrointestinal dysmotility</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1882</id><symptom>growth retardation, poor growth</symptom><category>GENERAL TOPICS | GENERAL TOPICS</category></symtomp><symtomp><id>2631</id><symptom>hypersalivation</symptom><category>GENERAL TOPICS | HEAD</category></symtomp><symtomp><id>1896</id><symptom>hypertonia, spasticity</symptom><category>MUSCLES</category></symtomp><symtomp><id>3627</id><symptom>hypokinesia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>1941</id><symptom>motor retardation / motor developmental delay</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>1787</id><symptom>muscle weakness</symptom><category>MUSCLES</category></symtomp><symtomp><id>2513</id><symptom>oculogyric crisis</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3311</id><symptom>Parkinsonism</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1919</id><symptom>progressive neurologic defect</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3680</id><symptom>psychomotor retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>3479</id><symptom>speech difficulties</symptom><category>LUNG OR RESPIRATORY SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1944</id><symptom>tremor or twitching</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites><metabolite><id>1624</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>1.80</min><max>12.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1702</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>decreased</value><min>1.00</min><max>3.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>2089</id><name>Biopterin</name><specimen>urine</specimen><value>decreased</value><min>0.50</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>2090</id><name>Biopterin</name><specimen>urine</specimen><value>decreased</value><min>0.50</min><max>2.70</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>2140</id><name>Prolactin</name><specimen>serum</specimen><value>decreased</value><min>4.79</min><max>23.30</max><unit>ng/ml</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>669</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>decreased</value><min>3.10</min><max>21.80</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>671</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>decreased</value><min>1.30</min><max>11.50</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>670</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>decreased</value><min>12.00</min><max>26.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>672</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>decreased</value><min>3.00</min><max>13.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>673</id><name>Vanillylmandelic acid (VMA)</name><specimen>urine</specimen><value>decreased</value><min>3.00</min><max>16.00</max><unit>mmol/mol creatinine</unit><age>adolescence</age><method /><comment /></metabolite><metabolite><id>1387</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>decreased</value><min>0.00</min><max>12.00</max><unit>mmol/mol creatinine</unit><age>childhood 4-6y</age><method /><comment /></metabolite><metabolite><id>910</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>120.00</min><max>500.00</max><unit>nmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>931</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>105.00</min><max>299.00</max><unit>nmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1001</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>decreased</value><min>    </min><max>11.50</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1388</id><name>5-Hydroxyindolacetic acid (5-HIAA)</name><specimen>urine</specimen><value>decreased</value><min>0.20</min><max>8.70</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>424</id><name>Biopterin</name><specimen>urine</specimen><value>decreased</value><min>0.50</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>425</id><name>Biopterin</name><specimen>urine</specimen><value>decreased</value><min>0.50</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>426</id><name>Biopterin</name><specimen>urine</specimen><value>decreased</value><min>0.50</min><max>2.70</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method /><comment /></metabolite><metabolite><id>934</id><name>Biopterin</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>10.00</min><max>50.00</max><unit>nmol/l</unit><age /><method /><comment /></metabolite><metabolite><id>684</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>3.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>685</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>2.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>686</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>6.00</min><max>42.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>687</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>1.00</min><max>14.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>688</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>1.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>2022</id><name>Homovanillic acid (HVA)</name><specimen>urine</specimen><value>decreased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>911</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>100.00</min><max>900.00</max><unit>nmol/l</unit><age>1m-2years</age><method /><comment /></metabolite><metabolite><id>932</id><name>Homovanillic acid (HVA)</name><specimen>cerebrospinal fluid</specimen><value>decreased</value><min>211.00</min><max>871.00</max><unit>nmol/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7579</id><title>Genetic study in a family with dopa-responsive dystonia revealed a novel mutation in sepiapterin reductase gene</title><author>Froukh T</author><journal>Pak J Med Sci</journal><year>2019</year><book /><volume>35</volume><number>6</number><pages>1736-1739</pages><co_aut /></literature><literature><id>7580</id><title>Leaky splicing variant in sepiapterin reductase deficiency: Are milder cases escaping diagnosis?</title><author>Nakagama Y,</author><journal>Neurol Genet</journal><year>2019</year><book /><volume>5</volume><number>2</number><pages>e319</pages><co_aut>et al.</co_aut></literature><literature><id>7581</id><title>Sepiapterin reductase deficiency: Report of 5 new cases</title><author>AlSubhi S,</author><journal>Eur J Paediatr Neurol</journal><year>2017</year><book /><volume>21</volume><number>3</number><pages>583-586</pages><co_aut>etv al.</co_aut></literature><literature><id>4975</id><title>Sepiapterin Reductase Deficiency</title><author>Friedman J</author><journal>GeneReviews&#174; [Internet]</journal><year>2015</year><book /><volume>0</volume><number>0</number><pages /><co_aut /></literature><literature><id>7582</id><title>Urine sepiapterin excretion as a new diagnostic marker for sepiapterin reductase deficiency</title><author>Carducci C,</author><journal>Mol Genet Metab</journal><year>2015</year><book /><volume>115</volume><number>4</number><pages>157-160</pages><co_aut>et al.</co_aut></literature><literature><id>7583</id><title>Dopamine-Responsive Growth-Hormone Deficiency and Central Hypothyroidism in Sepiapterin Reductase Deficiency</title><author>Zielonka M,</author><journal>JIMD Rep</journal><year>2015</year><book /><volume>24</volume><number>0</number><pages>109-113</pages><co_aut>et al.</co_aut></literature><literature><id>2812</id><title>Two Greek siblings with sepiapterin reductase deficiency</title><author>Verbeek MM,</author><journal>Mol Genet Metab</journal><year>2008</year><book /><volume>94</volume><number>4</number><pages>403-409</pages><co_aut>et al.</co_aut></literature><literature><id>2433</id><title>Sepiapterin reductase deficiency: a congenital dopa-responsive motor and cognitive disorder</title><author>Neville BG</author><journal>Brain</journal><year>2005</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>2047</id><title>Detection of sepiapterin in CSF of patients with sepiapterin reductase deficiency</title><author>Zorzi G</author><journal>Mol Genet Metab</journal><year>2002</year><book /><volume>75</volume><number>2</number><pages>174-177</pages><co_aut>et al.</co_aut></literature><literature><id>2046</id><title>Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency w</title><author>Bonafe L</author><journal>Am J Hum Genet</journal><year>2001</year><book /><volume>69</volume><number>2</number><pages>269-277</pages><co_aut>et al.</co_aut></literature><literature><id>7584</id><title>Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapte</title><author>Blau N,</author><journal>Mol Genet Metab</journal><year>2001</year><book /><volume>74</volume><number>1</number><pages>172-185</pages><co_aut>et al.</co_aut></literature><literature><id>1308</id><title>Variant of dihydropteridine reductase deficiency without hyperphenylalaninaemia: effect of oral phenylalanine loading</title><author>Blau N</author><journal>J Inherit Metab Dis</journal><year>1999</year><book /><volume>22</volume><number>3</number><pages>2316-220</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>